Stocks Slip as Pand...
Health Care: Health Services
BG Medicine Inc. (BGMD: NASDAQ)
$1.72 -0.07 | -3.91%
05/24/13 - 04:00 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
| BGMD | Sector Avg. | S&P 500 |
|---|---|---|
| n/a | 0.00 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| -6.28 | -56.57 | 0.00 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 72.30 | -0.67 | -0.31 |
| Net Income | 0.00 | 0.00 | |
| EPS | -0.09 | 0.00 |
Earnings for BGMD:
| EBITDA | -22.00 |
| REVENUE | 2.82M |
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $-0.20 | $-0.19 | $-0.75 | $-0.47 |
| Number of Analysts | 1 | 1 | 2 | 2 |
| High Estimate | $-0.20 | $-0.19 | $-0.73 | $-0.44 |
| Low Estimate | $-0.20 | $-0.19 | $-0.77 | $-0.51 |
| Prior Year | $-0.32 | $-0.34 | $-1.18 | $-0.75 |
| Growth Rate (Year over Year) | 37.50% | 44.12% | 36.44% | 36.67% |
Portfolios with BGMD
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks With Big Insider Buy...
- ContributorUnder-$10 Setting Up To Tra...
- Contributor8 Health Care Stocks With R...
Latest BGMD Headlines from TheStreet
- 8 Stocks Under $10 Trending Sharply Higher 05.14.13 | 11:05 pm
- BG Medicine, Inc. Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 05.10.13 | 05:05 pm
- BG Medicine Appoints Dr. Paul Sohmer As Chief Executive Officer 05.09.13 | 07:05 am
- BG Medicine Reports 2013 First Quarter Financial Results 05.09.13 | 07:05 am
- Trenton Health Team Adopts Novel Diagnostic Tool, BGM Galectin-3(R) Test, To Reduce Hospital Readmissions 05.08.13 | 07:05 am
- BG Medicine To Announce First Quarter 2013 Financial Results And Host Conference Call On Thursday, May 9, 2013 05.02.13 | 08:05 am
- BG Medicine Welcomes CE Mark For Galectin-3 Test 04.10.13 | 08:04 am
- BG Medicine Reports Fourth Quarter And Full Year 2012 Financial Results And Provides 2013 Outlook 03.13.13 | 07:03 am
- BG Medicine To Announce Fourth Quarter And Year-End 2012 Financial Results And Host Conference Call On Wednesday, March 13, 2013 03.06.13 | 08:03 am
- BG Medicine Highlights Role Of Galectin-3 Testing In Combating Hospital Readmissions At The American College Of Cardiology's (ACC) 62nd Annual Scientific Session & Expo 03.06.13 | 08:03 am
Press Releases for BGMD
- Abbott's Galectin-3 Test Provides Doctors In Europe With New Tool For Assessing The Prognosis Of Chronic Heart Failure Patients - PR Newswire 04.10.13 | 08:04 am
- Health Diagnostic Laboratory, Inc. (HDL, Inc.) Announces Availability Of Galectin-3 Testing Service In Partnership With BG Medicine - PR Newswire 03.24.11 | 08:03 am
- BG Medicine Announces Exercise Of Underwriters’ Over-Allotment Option And Closing Of Initial Public Offering - Business Wire 02.09.11 | 04:02 pm
- BG Medicine Announces Pricing Of Initial Public Offering - Business Wire 02.04.11 | 08:02 am
Partner Headlines for BGMD
- Pre-Market Most Active for Dec 12, 2012 : TLAB, QQQ, NRF, STM, BAC, NOK, LLY, AIG, SIRI, BGMD, FB, AAPL - NASDAQ 12.12.12 | 01:12 pm
- 4 Undervalued And Technically Oversold Healthcare Penny Stocks Poised To Bounce - Seeking Alpha 11.20.12 | 09:11 am
- UPDATE: Ladenburg Thalmann Raises PT to $16.50 on BG Medicine - Benzinga 02.14.12 | 01:02 pm
- Market Update - Benzinga 01.09.12 | 09:01 am
